webinar register page

Webinar banner
Renal Autologous Cell Therapy (REACT) for CKD: Investigative Trials for Type 2 Diabetic CKD
Join the NKF, NKFAZ and ProKidney for a virtual professional education and networking event to highlight current cell-based CKD trials and interim results related to eGFR and UACR improvements.

This discussion will cover:
• Limitations of current standard of care in CKD management.
• REACT has the potential to stabilize renal function to delay or avoid dialysis.
• REACT has the potential to reduce CKD inflammation and fibrosis.

Nov 9, 2022 06:00 PM in Arizona

Webinar logo
* Required information


Arnold Silva, MD
Nephrologist and Director of Clinical Research @Boise Kidney and Hypertension
Joe Stavas, MD
Senior Vice President Clinical Development @ProKidney
Kerry Cooper, MD
Nephrologist, Senior Vice President Medical Affairs @ProKidney